These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
87 related articles for article (PubMed ID: 20621515)
1. Interleukin-1 receptor antagonist in animal models of stroke: a fair summing up? Parry-Jones A; Boutin H; Denes A; McColl B; Hopkins S; Allan S; Tyrrell P J Stroke Cerebrovasc Dis; 2010; 19(6):512-3. PubMed ID: 20621515 [No Abstract] [Full Text] [Related]
2. Systematic review and stratified meta-analysis of the efficacy of interleukin-1 receptor antagonist in animal models of stroke. Banwell V; Sena ES; Macleod MR J Stroke Cerebrovasc Dis; 2009; 18(4):269-76. PubMed ID: 19560680 [TBL] [Abstract][Full Text] [Related]
3. A cross-laboratory preclinical study on the effectiveness of interleukin-1 receptor antagonist in stroke. Maysami S; Wong R; Pradillo JM; Denes A; Dhungana H; Malm T; Koistinaho J; Orset C; Rahman M; Rubio M; Schwaninger M; Vivien D; Bath PM; Rothwell NJ; Allan SM J Cereb Blood Flow Metab; 2016 Mar; 36(3):596-605. PubMed ID: 26661169 [TBL] [Abstract][Full Text] [Related]
4. [In vivo exploration of cerebral ischemia: use of neuroprotective agents in animal studies]. Lestage P; Lockhart B; Roger A Therapie; 2002; 57(6):554-63. PubMed ID: 12666263 [TBL] [Abstract][Full Text] [Related]
5. [Thrombolytic therapy in acute ischemic stroke. Critical analysis of current knowledge]. Murray V; Norrving B; Terént A; Wester P Lakartidningen; 2004 Feb; 101(8):662-8, 670-3. PubMed ID: 15024939 [TBL] [Abstract][Full Text] [Related]
6. Animal models of ischemic stroke: balancing experimental aims and animal care. Graham SM; McCullough LD; Murphy SJ Comp Med; 2004 Oct; 54(5):486-96. PubMed ID: 15575362 [TBL] [Abstract][Full Text] [Related]
7. Overview: the search for therapeutic strategies for cerebrovascular ischemia. Kumar K Curr Opin Investig Drugs; 2003 Jan; 4(1):28-30. PubMed ID: 12625024 [No Abstract] [Full Text] [Related]
8. Susceptibility for ischemic stroke in Korean population is associated with polymorphisms of the interleukin-1 receptor antagonist and tumor necrosis factor-alpha genes, but not the interleukin-1beta gene. Lee BC; Ahn SY; Doo HK; Yim SV; Lee HJ; Jin SY; Hong SJ; Lee SH; Kim SD; Seo JC; Leem KH; Chung JH Neurosci Lett; 2004 Feb; 357(1):33-6. PubMed ID: 15036607 [TBL] [Abstract][Full Text] [Related]
9. Inflammatory markers for ischaemic stroke. Pola R Thromb Haemost; 2009 May; 101(5):800-1. PubMed ID: 19404529 [No Abstract] [Full Text] [Related]
10. Therapeutic neutralization of CD95-ligand and TNF attenuates brain damage in stroke. Martin-Villalba A; Hahne M; Kleber S; Vogel J; Falk W; Schenkel J; Krammer PH Cell Death Differ; 2001 Jul; 8(7):679-86. PubMed ID: 11464212 [TBL] [Abstract][Full Text] [Related]
12. Neuroprotective and neuroproliferative activities of NeuroAid (MLC601, MLC901), a Chinese medicine, in vitro and in vivo. Heurteaux C; Gandin C; Borsotto M; Widmann C; Brau F; Lhuillier M; Onteniente B; Lazdunski M Neuropharmacology; 2010 Jun; 58(7):987-1001. PubMed ID: 20064536 [TBL] [Abstract][Full Text] [Related]
13. Neuroprotective effect of simvastatin in stroke: a comparison between adult and neonatal rat models of cerebral ischemia. Cimino M; Balduini W; Carloni S; Gelosa P; Guerrini U; Tremoli E; Sironi L Neurotoxicology; 2005 Oct; 26(5):929-33. PubMed ID: 15923039 [TBL] [Abstract][Full Text] [Related]